Bayer CEO Marijn Dekkers calls for greater appreciation of innovation
- Details
- Category: Bayer
Advances in cancer therapy are expected in the next years thanks in particular to treatment using antibody-drug conjugates and multi-kinase inhibitors. This is the finding from a TNS Emnid survey of medical experts at the "Science For A Better Life" symposium organized by Bayer. This event saw 380 scientists from 14 countries come together at the Bayer Kasino in Leverkusen in November.
Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children
- Details
- Category: GlaxoSmithKline
A simple low-cost device that helps newborn babies to breathe and has the potential to transform the life chances for thousands of African babies has been awarded the highest fund in the first GSK and Save the Children $1 million Healthcare Innovation Award.
Bristol-Myers Squibb Foundation marks World Diabetes Day with four grants addressing link between diabetes, depression and distress
- Details
- Category: Bristol-Myers Squibb
The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the third anniversary of its Together on Diabetes initiative by announcing four new grants focusing on the important link between type 2 diabetes, depression and distress. Together on Diabetes also issued its third annual report.
Experience a day in the life of an insulin-using patient with diabetes through interactive infographic
- Details
- Category: Abbott
In honor of World Diabetes Day, Abbott has created an interactive infographic to help raise awareness about what life can be like for an insulin-using patient who has diabetes. Approximately 26 percent of the 18.8 million Americans diagnosed with diabetes follow an insulin regimen recommended by their healthcare provider in order to manage their condition.
Novartis announces positive clinical trial results for novel H7N9 vaccine
- Details
- Category: Novartis
Novartis announced today interim results from a Phase 1 clinical trial with its proprietary cell culture vaccine for the H7N9 avian influenza virus involving 400 healthy volunteers (18-64 years of age). The data shows 85% of subjects achieved a protective immune response after two doses of the 15 ug MF59 adjuvanted vaccine.
Bristol-Myers Squibb announces changes in its senior management team
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) has announced a series of related changes within its Senior Management Team. To support its ongoing success as a BioPharma leader, the company is evolving its business model, creating a global integrated commercial organization and expanding the scope of its finance organization.
Merck Serono announces five-year strategic partnership with the Lead Discovery Center
- Details
- Category: Merck Group
Merck Serono, the biopharmaceutical division of Merck, has announced a five-year strategic partnership with the Lead Discovery Center GmbH (LDC), Dortmund, Germany, a renowned translational research organization. This collaboration integrates the expertise and resources of both organizations to expedite the discovery of promising lead structures and to optimize the development of therapeutic candidates in areas of high unmet medical need.
More Pharma News ...
- AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex
- GSK names inaugural winners in unique competition for academic drug hunters
- Amgen Foundation commits $2.5 million in new grants to engage 50,000 students each year in the thrill of scientific inquiry
- The solid momentum continues - New Products up by 41%
- Novo Nordisk and Oxford University join forces to further enhance diabetes research
- Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections
- Bayer continues positive business momentum